Preanalytical
Systems $ 541,415 $ 511,948 5.8
Diagnostic Systems 512,973 407,123 26.0
TOTAL $ 1,054,388 $ 919,071 14.7
BD BIOSCIENCES
Discovery Labware $ 149,939 $ 138,205 8.5
Immunocytometry
Systems 210,916 186,369 13.2
Pharmingen 79,454 77,622 2.4
TOTAL $ 440,309 $ 402,196 9.5
TOTAL UNITED STATES $ 3,033,005 $ 2,739,344 10.7
BECTON DICKINSON AND COMPANY
SUPPLEMENTAL REVENUE INFORMATION
REVENUES BY BUSINESS SEGMENTS AND UNITS
Twelve Months Ended September 30, (continued)
(Unaudited; Amounts in thousands)
International
% Change
-------------------------
FX FX
2007 2006 Reported Neutral Impact
BD MEDICAL
Medical Surgical
Systems $ 909,109 $ 844,372 7.7 2.8 4.9
Diabetes Care 317,342 293,235 8.2 3.3 4.9
Pharmaceutical
Systems 611,563 511,798 19.5 12.5 7.0
Ophthalmic Systems 44,348 39,164 13.2 6.7 6.5
TOTAL $ 1,882,362 $ 1,688,569 11.5 5.9 5.6
BD DIAGNOSTICS
Preanalytical
Systems $ 465,276 $ 415,811 11.9 6.2 5.7
Diagnostic Systems 385,441 380,208 1.4 (2.5) 3.9
TOTAL $ 850,717 $ 796,019 6.9 2.0 4.9
BD BIOSCIENCES
Discovery Labware $ 127,963 $ 117,880 8.6
'/>"/>
| SOURCE BD (Becton Dickinson and Company) Copyright©2007 PR Newswire. All rights reserved |